Go Pro

Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest in Omron jumped sharply in June, rising 249.5% to 32,332 shares as of June 30 from 9,250 shares two weeks earlier. Despite the increase, only 0.0% of shares were sold short, and the days-to-cover ratio was just 0.1 days.
  • A hedge fund, GAMMA Investing LLC, increased its Omron stake by 50.7% in the fourth quarter, bringing its holding to 2,129 shares valued at about $54,000. Institutional investors and hedge funds now own 1.09% of the stock.
  • Analyst sentiment has weakened, with Zacks cutting Omron to strong sell and Jefferies lowering it to hold. The stock opened at $37.34, near its 50-day and 200-day moving averages, and carries an average analyst rating of Reduce.
  • MarketBeat previews top five stocks to own in August.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 32,332 shares, an increase of 249.5% from the June 15th total of 9,250 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 281,273 shares, the days-to-cover ratio is currently 0.1 days.

Hedge Funds Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its position in Omron Corp. (OTCMKTS:OMRNY - Free Report) by 50.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,129 shares of the company's stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $54,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 1.09% of the stock is currently owned by institutional investors and hedge funds.

Omron Stock Performance

OTCMKTS OMRNY opened at $37.34 on Monday. The stock's 50-day simple moving average is $36.30 and its two-hundred day simple moving average is $31.42. Omron has a twelve month low of $23.23 and a twelve month high of $40.76. The company has a quick ratio of 1.41, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $7.34 billion, a price-to-earnings ratio of 39.31, a PEG ratio of 0.46 and a beta of 1.14.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on OMRNY shares. Zacks Research cut shares of Omron from a "hold" rating to a "strong sell" rating in a research report on Thursday, June 11th. Jefferies Financial Group lowered shares of Omron from a "buy" rating to a "hold" rating in a research report on Tuesday, June 16th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Reduce".

View Our Latest Analysis on Omron

Omron Company Profile

(Get Free Report)

Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines